| 张文宇1 蒋萌2 陈翎2.围术期应用肼苯哒嗪预防疝修补术后慢性疼痛的研究[J].,2011,11(21):4144-4146 |
| 围术期应用肼苯哒嗪预防疝修补术后慢性疼痛的研究 |
| Perioperative Administration of Hydralazine Prevents PostoperativeChronic Pain After Herniorrhaphy |
| |
| DOI： |
| 中文关键词: 肼苯哒嗪 疝修补术 急性疼痛 术后慢性疼痛 |
| 英文关键词: Hydralazine Herniorrhaphy Acute Pain Postoperative Chronic Pain |
| 基金项目: |
|
| 摘要点击次数: 614 |
| 全文下载次数: 749 |
| 中文摘要: |
| 目的：探讨肼苯哒嗪对疝修补术后患者慢性疼痛发生率的影响。方法：选择单侧腹股沟疝患者48人，随机分为实验组（T组）
和对照组（C 组）各24 例，在术前3 天至术后4 天共7 天内接受药物或安慰剂治疗。其中T 组每日两次，每次10mg 肼苯哒嗪，C
组同样方式给予安慰剂。测量患者术后4天内的平均动脉压（MAP）、心率（HR）、NRS急性疼痛评分以及术后3月、6月S-LANSS
慢性疼痛评分。结果：T 组患者术后MAP明显低于C 组（P<0.05），HR 两组相比无差异（P>0.05）；两组患者术后急性疼痛程度相
比无统计学差别（P>0.05）；T组患者在术后3月和6月慢性疼痛发生率明显低于C 组（P<0.05）。结论：常规剂量肼苯哒嗪可以用
于术后患者，对疝修补术后急性疼痛无影响，但可以明显降低术后慢性疼痛的发生率。 |
| 英文摘要: |
| Objective: To explore the role of hydralazine in prevention of postoperative chronic pain. Methods: 48 patients with
herniorrhaphy were randomly divided into Test group (T group, n=24) and Control group (C group, n=24). The patients in T group were
treated with 10 mg hydralazine BID, and the patients in C group was administered with placebo in the same manner. The MAP, HR, NRS
score were measured during the first four days after operation, and S-LANSS scores were reported by every available patient at 3 and 6
months postoperatively. Results: The MAP level of T group patients was significantly lower than that of C group （P<0.05）; HR in the
two groups has no signicant difference（P>0.05）.There was no significant differences of NRS scores in the two groups（P>0.05）. The incidences
of postoperative chronic pain was obviously lower in T group than those in C group（P<0.05）. Conclusions: Hydralazine can obviously
decrease the incidence of postoperative chronic pain rather than the acute pain in patients after herniorrhaphy. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
